February 15, 2018 / 11:00 PM / 7 months ago

BRIEF-Akcea Therapeutics says ‍FDA Advisory Committee Meeting To Review Data Supporting Volanesorsen NDA

Feb 15 (Reuters) - Akcea Therapeutics Inc:

* AKCEA THERAPEUTICS- ‍FDA ADVISORY COMMITTEE MEETING TO REVIEW DATA SUPPORTING VOLANESORSEN NDA; MEETING TENTATIVELY SCHEDULED FOR MAY 10

* AKCEA THERAPEUTICS INC - ‍ FDA SET A PDUF GOAL DATE OF AUGUST 30, 2018 FOR COMPLETION OF REVIEW​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below